HIV persistence despite reservoir decay during combinatorial immunotherapy including therapeutic conserved elements (CE) DNA vaccination, αPD-1 therapy, GS-986 TLR7-agonism, and CCR5 gene-edited CD4 T cell infusion in rhesus macaques

• S. Dross,
• C. Peterson,
• M. O’Connor,
• H. Tunggal,
• J. Li,
• K. Jerome,
• H.P. Kiem,
• B. Felber,
• J. Mullins,
• D. Fuller

Affiliations

S. Dross

Department of Microbiology, University of Washington, Seattle, USA

C. Peterson

Fred Hutchinson Cancer Research Center, Seattle, USA

M. O’Connor

Department of Microbiology, University of Washington, Seattle, USA

H. Tunggal

Department of Microbiology, University of Washington, Seattle, USA

J. Li

Department of Microbiology, University of Washington, Seattle, USA

K. Jerome

Fred Hutchinson Cancer Research Center, Seattle, USA

H.P. Kiem

Fred Hutchinson Cancer Research Center, Seattle, USA

B. Felber

Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, USA

J. Mullins

Department of Microbiology, University of Washington, Seattle, USA

D. Fuller

Department of Microbiology, University of Washington, Seattle, USA